SubsidieMeestersEndothelial immunosuppressive mystery genes for alternative immunotherapy: artificial intelligence-driven target discovery and lipid nanoparticle/RNA-based target validation
This project aims to enhance cancer immunotherapy by targeting immunomodulatory endothelial cell subtypes and utilizing AI and innovative gene editing technologies to identify and validate new therapeutic targets.
Projectdetails
Introduction
Compared to my previous Advanced ERC grants, this proposal is fundamentally different not only concerning its topic but also regarding its ambition to offer greater societal impact by coupling knowledge gain tighter to translation.
Objectives
It promises to obtain new insights in an understudied endothelial cell (EC) subtype with immunomodulatory gene signatures (coined “IMECs”), highly relevant for alternative immunotherapy development. Indeed, silencing immunosuppressive genes in IMECs offers unprecedented opportunities to improve the efficacy of and to overcome the resistance to current anti-cancer immunotherapy, to which the immunosuppressive tumor endothelium contributes.
Research Focus
To identify previously unknown/unmined (“virgin”) drug targets, we also focus on “mystery” genes, lacking functional annotation / PubMed reports (comprising 30% of the human coding genome).
Methodology
We developed:
- An innovative artificial intelligence (AI)-based tool (SCMYSTERYDENTIFIER) to predict new immunosuppressive functions for endothelial “mystery” genes.
- A revolutionizing (“REVOLT”) technology (based on injecting EC-selective lipid nanoparticles containing sgRNA in mice expressing Cas9 selectively in ECs) to generate EC-specific knockout mice rapidly (days) / inexpensively (300€/mouse) at an unprecedented scale in order to validate these targets.
Expected Outcomes
Demystifying the mystery genome offers formidable opportunities for knowledge gain and therapy development. We will validate 50 new EC targets and aspire to identify and patent 5 previously unknown targets for alternative IMEC-based immunotherapy.
Broader Impact
The SCMYSTERYDENTIFIER tool can be made generic to discover any type of function for mystery genes in any cell type, while the REVOLT technology promises to revolutionize the pace of genetic research in the vascular biology field, offering formidable impact for the research community in academia and pharma.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 3.498.426 |
| Totale projectbegroting | € 3.498.426 |
Tijdlijn
| Startdatum | 1-3-2023 |
| Einddatum | 29-2-2028 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- VIB VZWpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
ModulatIng Cancer therapy RespOnse using Bacterial Extracellular nanovesiclesThe MICROBE project aims to develop innovative BEV nanotherapeutics from gut bacteria to enhance immune checkpoint inhibitor responses in cancer treatment through mechanistic analysis and clinical application. | ERC COG | € 2.000.000 | 2022 | Details |
Overcoming resistance to immunotherapy: Immunostimulatory tumor-derived extracellular vesicles as multifunctional anticancer agentsIMMUNO-TEX aims to develop tumor-derived immunostimulatory extracellular vesicles to enhance antitumor immunity and overcome resistance to immune checkpoint inhibitors in poorly immunogenic tumors. | ERC STG | € 1.650.778 | 2023 | Details |
Unlocking a T cell-mediated Immune response in therapy-challenged TumorsUnlockIT aims to develop mechanism-based combination therapies for cancer by understanding tumor-immune interactions and enhancing T cell responses in therapy-challenged tumors. | ERC COG | € 2.000.000 | 2024 | Details |
Targeting the vascular-immune interface to induce anti-tumor immunityThis project aims to enhance cancer immunotherapy by characterizing the vascular-immune interface in melanoma and glioblastoma to optimize immune responses through targeted therapeutic induction. | ERC SyG | € 9.453.750 | 2025 | Details |
ModulatIng Cancer therapy RespOnse using Bacterial Extracellular nanovesicles
The MICROBE project aims to develop innovative BEV nanotherapeutics from gut bacteria to enhance immune checkpoint inhibitor responses in cancer treatment through mechanistic analysis and clinical application.
Overcoming resistance to immunotherapy: Immunostimulatory tumor-derived extracellular vesicles as multifunctional anticancer agents
IMMUNO-TEX aims to develop tumor-derived immunostimulatory extracellular vesicles to enhance antitumor immunity and overcome resistance to immune checkpoint inhibitors in poorly immunogenic tumors.
Unlocking a T cell-mediated Immune response in therapy-challenged Tumors
UnlockIT aims to develop mechanism-based combination therapies for cancer by understanding tumor-immune interactions and enhancing T cell responses in therapy-challenged tumors.
Targeting the vascular-immune interface to induce anti-tumor immunity
This project aims to enhance cancer immunotherapy by characterizing the vascular-immune interface in melanoma and glioblastoma to optimize immune responses through targeted therapeutic induction.